When comparing the difference in the DEGs by recurrence status in both age groups, we found that MAPK11 was highly expressed in the younger melanoma patients in the recuryes versus the recurno group (FC=2.84) (Table 6). This evidence concerns the gene MAPK11 and melanoma.